Envista Holdings Corporation (NVST) reported adjusted earnings per share (EPS) of 11 cents for secondquarter 2024, down 74.4% year over year. The bottom line missed the Zacks Consensus Estimate by 59.3%. The adjustments include a $1.15 billion non-cash charge related to the impairment of goodwill and intangible assets, charges and benefits related to the amortization of acquired intangible assets and restructuring costs, among others. The company's GAAP loss was $6.69 compared with the year-ago quarter's ea ...

Envista Holdings Corporation (NYSE:NVST) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Stephen Keller - Principal Financial Officer Paul Keel - CEO Eric Hammes - Incoming CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Erin Wright - Morgan Stanley & Co. Jon Block - Stifel, Nicolaus & Company Jeff Johnson - Robert W. Baird & Co. Brandon Vazquez - William Blair & Company Kevin Caliendo - UBS Securities Dan Clark - Leerink Partners Jason Bednar - Piper Sandl ...

Envista (NVST) reported $633.1 million in revenue for the quarter ended June 2024, representing a year-overyear decline of 4.4%. EPS of $0.11 for the same period compares to $0.43 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $647.99 million, representing a surprise of -2.30%. The company delivered an EPS surprise of -59.26%, with the consensus EPS estimate being $0.27. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

Envista (NVST) came out with quarterly earnings of $0.11 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.43 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of -59.26%. A quarter ago, it was expected that this maker of dental products would post earnings of $0.31 per share when it actually produced earnings of $0.26, delivering a surprise of -16.13%. Over the last four quarters, ...

Exhibit 99.1 Envista Reports Second Quarter 2024 Results Brea, California, August 7, 2024 – Envista Holdings Corporation (NYSE: NVST) today announced results for the second quarter of 2024. For the quarter ended June 28, 2024, reported sales were $633.1 million. Core sales in the quarter declined 3.2% over the corresponding quarter in 2023. Net loss in the second quarter was $1,151.6 million or $6.69 per share. The net loss included a $1,153.8 million non-cash charge related to the impairment of goodwill an ...

Analysts on Wall Street project that Envista (NVST) will announce quarterly earnings of $0.27 per share in its forthcoming report, representing a decline of 37.2% year over year. Revenues are projected to reach $647.99 million, declining 2.2% from the same quarter last year. Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 4.2% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period. ...

Eric Hammes joins Envista as Chief Financial Officer Stefan Nilsson joins Envista as President, Nobel Biocare Veronica Acurio joins Envista as President, Ormco Eric Hammes is appointed Chief Financial Officer effective August 8, 2024. He succeeds Stephen Keller who has served as Interim Principal Financial Officer since September 2023. Mr. Keller will return to his previous role leading investor relations. Mr. Hammes said, "I am thrilled to join Envista at this exciting time in the company's history. Envist ...

The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can access the conference call by dialing 800-579- 2543 within the U.S. or +1 785-424-1789 outside the U.S. a few minutes before 2:00 PM PT and referencing conference ID #9467851. ABOUT ENVISTA HOLDINGS CORPORATION FOR FURTHER INFORMATION Steph ...

BREA, Calif., June 3, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") and its charitable arm, the Envista Smile Project, announced today that it has partnered with the University of Southern California's (USC) Herman Ostrow School of Dentistry and committed a $2.1 million donation to USC's Dental Health Equity and Access to Care Initiative. The gift is part of both organizations' commitment to expand and improve access to oral health for those in need. FOR FURTHER INFORMATION Meli ...

Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide array of dentists' clinical need ...